Published December 27, 2024
Researchers on limited budgets may find injection more economical despite the additional supplies required
The FDAs shortage list maintains the status of semaglutide as currently in shortage, although only one presentation Wegovy 0.25 mg/0.5 mL is marked for limited availability
We tried it, but she didnt tolerate it she became nauseous and lost weight she didnt need. In this case, the risk outweighed the potential benefits, raising the question of whether GLP-1s offer the same longevity advantages for people without a medical indication for their use
Much of this evidence comes from preclinical models, so human conclusions remain limited
Kashyap SR, Bhatt DL, Wolski K, Watanabe RM, Abdul-Ghani M, Abood B, Pothier CE, Brethauer S, Nissen S, Gupta M, Kirwan JP, Schauer PR